The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Inflation in 2025 remained above the Federal Reserve's 2% target, even as price pressures eased slightly later in the year

  80% confidence

• Johnson & Johnson currently has a Zacks Rank #2 (Buy)

  80% confidence

• Invesco's robust AUM balance, diverse product offerings, strong balance sheet and global presence will keep supporting financials, and synergies from acquisitions will keep aiding profitability

  80% confidence

• Bunge pays out a quarterly dividend of 70 cents ($2.80 annualized) per share, yielding 3.06% at the current stock price; BG's payout ratio is 37%, with a five-year dividend growth rate of 8.58%

  80% confidence

• Johnson & Johnson pays out a quarterly dividend of $1.30 ($5.20 annualized) per share, with a 2.52% yield at the current stock price; JNJ's payout ratio is 50%, with a five-year dividend growth rate of 5.39%

  80% confidence

• Invesco currently sports a Zacks Rank #1 (Strong Buy)

  80% confidence

• Real GDP growth for 2025 is projected at about 2%, reflecting steady but below-trend expansion compared with historical averages

  80% confidence

• Inflation is projected to gradually moderate in 2026, allowing the Federal Reserve greater flexibility to pivot toward a more accommodative policy stance

  80% confidence

• NiSource expects to invest $28 billion in 2026-2030 in modernizing infrastructure to enhance the reliability of its operations

  80% confidence

• Real GDP growth is expected to hover near 2% for 2026, reflecting a slowdown from post-pandemic peaks but signaling continued economic resilience rather than contraction

  80% confidence

• Invesco pays out a quarterly dividend of 21 cents (84 cents annualized) per share, with a 3.11% yield at the current stock price; IVZ's payout ratio is 44%, with a five-year dividend growth rate of 7%

  80% confidence

• Zacks top stock-picking strategies have returned average gains of +48.4%, +50.2% and +56.7% per year since 2000, compared to the S&P's +7.7% average gain per year

  80% confidence

• Invesco currently sports a Zacks Rank #1 (Strong Buy)

  80% confidence

• Invesco's robust AUM balance, diverse product offerings, strong balance sheet and global presence will keep supporting financials; synergies from acquisitions will keep aiding profitability

  80% confidence

• Since 2000, Zacks top stock-picking strategies have achieved average gains of +48.4%, +50.2% and +56.7% per year, versus the S&P's +7.7% average gain per year

  80% confidence

• Bunge is executing a fundamental transformation anchored by the Viterra merger, expanding global origination, processing scale and logistics efficiency

  80% confidence

• Morgan Stanley currently has a Zacks Rank #2 (Buy)

  80% confidence

• NiSource pays out a quarterly dividend of 28.7 cents ($1.12 annualized) per share, yielding 2.7% at the current stock price; NI's payout ratio is 60%, with a five-year dividend growth rate of 6.22%

  80% confidence

• NiSource carries a Zacks Rank #2 (Buy)

  80% confidence

• The labor market cooled in 2025, with unemployment rising to 4.6%, its highest level in several years

  80% confidence

• The labor market cooled in 2025, with unemployment rising to 4.6%, its highest level in several years, and wage growth trending lower

  80% confidence

• Morgan Stanley currently has a Zacks Rank #2 (Buy)

  80% confidence

• Morgan Stanley pays out a quarterly dividend of $1.00 ($4.00 annualized) per share, with a 2.26% yield at the current stock price; MS's payout ratio is 41%, with a five-year dividend growth rate of 20.35%

  80% confidence

• NiSource carries a Zacks Rank #2 (Buy)

  80% confidence

• Strategic alliances and Morgan Stanley's increased focus on less capital market-dependent operations are expected to aid growth, with enhanced capital distribution activities reflecting a solid balance sheet

  80% confidence

• Real GDP rebounded sharply in the second quarter of 2025, expanding 3.8%, according to the U.S. Bureau of Economic Analysis's third estimate, marking a 0.5-percentage-point upward revision driven primarily by stronger-than-expected consumer spending

  80% confidence

• Real GDP rebounded sharply in the second quarter of 2025, expanding 3.8%, according to the U.S. Bureau of Economic Analysis's third estimate, a 0.5-percentage-point upward revision driven primarily by stronger-than-expected consumer spending

  80% confidence

• Johnson & Johnson currently has a Zacks Rank #2 (Buy)

  80% confidence

• Real GDP growth for 2025 is projected at about 2%, reflecting steady but below-trend expansion compared with historical averages

  80% confidence

• Johnson & Johnson's biggest strength is its diversified business model operating through pharmaceuticals and medical devices divisions with more than 275 subsidiaries

  80% confidence

Data points we hold from this source